DiVincenzo Jonathan P. 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Feb 8, 2024
Insider Transaction Report
Form 4
DiVincenzo Jonathan
EVP, Pres, Central Labs & Intl
Transactions
- Tax Payment
Common Stock
2024-02-07$223.71/sh−78$17,449→ 3,661.549 total - Exercise/Conversion
Common Stock
2024-02-07+138→ 3,799.549 total - Tax Payment
Common Stock
2024-02-07$223.71/sh−41$9,172→ 3,758.549 total - Exercise/Conversion
Common Stock
2024-02-07+224→ 3,739.549 total - Award
Restricted Stock Unit
2024-02-06+980→ 5,540 total→ Common Stock (980 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-02-07−138→ 5,178 total→ Common Stock (138 underlying) - Award
Non-qualified Stock Options
2024-02-06+3,000→ 3,000 totalExercise: $222.28From: 2025-02-06Exp: 2034-02-05→ Common Stock (3,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-02-07−224→ 5,316 total→ Common Stock (224 underlying)
Footnotes (7)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F5]Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- [F6]The option vests in three equal annual installments beginning on the date reflected in this column.
- [F7]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.